Mitokinin, Inc. — Form D
Mitokinin, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-16. The offering totals $6.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-11-16
- Form: D
- Accession: 0001717169-18-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $5.0M
- Remaining: $1.0M
- Investors: 3
- Date of first sale: 2018-10-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-326016
Issuer
- Name: Mitokinin, Inc.
- CIK: 0001717169
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 45 BROADWAY, SUITE 1440, NEW YORK, NY, 10006
- Phone: (347)668-8061
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Douglas Crawford | Director | San Francisco, CA |
| Daniel de Roulet, Jr. | Director | New York, NY |
| Nicholas Hertz | Director | San Francisco, CA |
| Peter Parker | Director | Boston, MA |
| Daniel de Roulet, Jr. | Executive Officer | New York, NY |
| Johannes Fruehauf | Director | Cambridge, MA |
| Doug Crawford | Director | San Francisco, CA |
Other filings by this issuer (1)
More